The Oncology Institute, Inc. (TOI) Dividend History

The Oncology Institute, Inc. (TOI) is a healthcare company focusing on providing specialized oncology care. It operates a network of outpatient clinics dedicated to the treatment of cancer, offering medical, radiation, and infusion services. The company emphasizes patient-centered care through a comprehensive approach, integrating advanced treatment options with supportive services.

18000 Studebaker Rd, Cerritos, CA, 90703
Phone: 562-735-3226
Website:

Dividend History

The Oncology Institute, Inc. currently does not pay dividends

Company News

  • The Oncology Institute Announces $16.5 million Private Placement

    The Oncology Institute, Inc. (TOI) announced a $16.5 million private placement with existing investors, management, and directors. The proceeds will be used for organic growth and working capital. The company also entered an exchange agreement with Deerfield Management Company to exchange convertible notes for preferred stock and warrants.

    GlobeNewswire Inc.
  • Grapevine Saves The Oncology Institute Millions On Healthcare Supplies

    Grapevine, a healthcare supply chain innovation company, has helped The Oncology Institute (TOI) achieve over $1.7 million in medical supply savings year to date. Grapevine's digital procurement platform has enabled TOI to diversify its supply chain, increase competition among suppliers, and significantly reduce patient care costs.

    GlobeNewswire Inc.
  • The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

    The Oncology Institute, LLC (TOI) announced that it will release its third quarter 2024 financial results on November 13, 2024, followed by a conference call. TOI is a value-based oncology group in the United States.

    GlobeNewswire Inc.
  • The Oncology Institute of Hope & Innovation Launches Oregon Market

    The Oncology Institute, Inc. (TOI) is expanding into Oregon with the opening of two new specialty cancer clinics in Portland and Salem. The new clinics will offer cutting-edge cancer care services and are part of TOI's commitment to value-based care and providing advanced treatment options to the community.

    GlobeNewswire Inc.
  • The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates

    The Oncology Institute (TOI) delivered earnings and revenue surprises of -83.33% and 0.53%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: ICCM
Dividend data last updated 06/07/2025 05:23:59 UTC